Microbiological and clinical studies on cefpodoxime proxetil for bacterial skin and soft tissue infections in pediatric patients
Ito, K.; Ito, M.
Journal of ChemoTherapy 7(Suppl 4): 124-126
1995
ISSN/ISBN: 1120-009X PMID: 8904131 Document Number: 445705
Document emailed within 1 workday
Related Documents
Kimura, S.; Yokoyama, M.; Kudo, M.; Aoyama, R.; Okamoto, T.; Tsushima, N.; Onodera, N.; Ikeda, Y. 1989: Clinical studies of cefpodoxime proxetil in pediatric field Japanese Journal of Antibiotics 42(7): 1477-1487Hirosawa, H.; Ishikawa, Y.; Takahashi, S.; Matsuda, H.; Ichihashi, H. 1989: Study of efficacy, safety and dosage on cefpodoxime proxetil in pediatric infections Japanese Journal of Antibiotics 42(7): 1498-1504
Kasagi, T.; Tanimoto, K.; Ogihara, Y.; Hayashibara, H.; Okuda, H.; Shiraki, K. 1994: The clinical study of cefpodoxime proxetil dry syrup preparation in the pediatric field Japanese Journal of Antibiotics 47(9): 1202-1209
Takeuchi, H.; Ikoma, H.; Suzuki, T.; Nakajima, M.; Kouzaki, Y.; Ishizu, Y.; Makino, H.; Sugihara, S.; Ootawara, S.; Asagi, K. 1994: Clinical evaluation of cefpodoxime proxetil in otorhinolaryngological infections Japanese Journal of Antibiotics 47(1): 84-92
Minamitani, M.; Hachimori, K.; Kaneda, K. 1989: A clinical evaluation of cefpodoxime proxetil in pediatrics Japanese Journal of Antibiotics 42(7): 1488-1497
Trilla, A.; Miro, J.M. 1995: Identifying high risk patients for Staphylococcus aureus infections: skin and soft tissue infections Journal of ChemoTherapy 7(Suppl 3): 37-43
Iakovlev, V.P.; Krutikov, M.G.; Blatun, L.A.; Izotova, G.N.; Grishina, I.A. 2000: Clinical and laboratory efficacy of the novel difluoroquinolone Sparflo (sparfloxacin) in therapy of skin and soft tissue infections Antibiotiki i Khimioterapiia 45(12): 37-40
Lundbergh, P. 2001: Clinical guidelines developed by the STRAMA group in the county of Stockholm: skin and soft tissue infections Lakartidningen 98(39): 4202-4205
Yokota, T.; Suzuki, E.; Arai, K. 1988: Cefpodoxime proxetil, its in vitro antibacterial activity, affinity to bacterial penicillin-binding proteins, and synergy of bactericidal activity with serum complement and mouse-cultured macrophages Drugs under Experimental and Clinical Research 14(8): 495-500
Motohiro, T.; Tanaka, K.; Koga, T.; Shimada, Y.; Tomita, N.; Nishiyama, T.; Ishimoto, K.; Tominaga, K.; Iriki, T.; Harada, M. 1985: Clinical trials of BRL 25000 (clavulanic acid-amoxicillin) granules on skin and soft tissue infections in the field of pediatrics Japanese Journal of Antibiotics 38(2): 507-537
Ottomano, C.; Frugoni, S.; Berlusconi, A.; Miseferi, G.; Mattina, R.; Anelli, M. 1991: In-vitro activity of cefpodoxime proxetil (RU 51807): a comparative disk diffusion study on isolates from geriatric patients Journal of ChemoTherapy 3(Suppl 1): 62-65
Gürlich, R.; Adámková, V.; Ulrych, J.; Brodská, H.; Janík, V.; Lindner, J.; Havel, E. 2016: Skin and soft tissue infections (SSTIs) Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 95(4): 141-146
Elston, D.M. 2004: Epidemiology and prevention of skin and soft tissue infections Cutis 73(5 Suppl): 3-7
Guchev, I.A.; Sidorenko, S.V.; Frantsuzov, V.N. 2003: Efficient antimicrobial chemotherapy for skin and soft tissue infections Antibiotiki i Khimioterapiia 48(10): 25-31
Cainzos Fernández, M. 1998: Skin and soft-tissue infections caused by Pseudomonas aeruginosa Revista Clinica Espanola 198 Suppl. 2: 21-24
Gupta, V.; Datta, P.; Singla, N. 2008: Skin and soft tissue infection: frequency of aerobic bacterial isolates and their antimicrobial susceptibility pattern Journal of the Association of Physicians of India 56: 389-390
Gandhi, S.V.; Patil, U.P.; Patil, N.G. 2009: Simultaneous spectrophotometric determination of Cefpodoxime proxetil and Potassium clavulanate Hindustan Antibiotics Bulletin 51(1-4): 24-28
Murakawa, G.J. 2004: Common pathogens and differential diagnosis of skin and soft tissue infections Cutis 73(5 Suppl): 7-10
Bradsher, R.W.; Snow, R.M. 1984: Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen American Journal of Medicine 77(4c): 63-67
Weiss, G.G. 2006: The role of fluoroquinolones in the management of skin, soft tissue, and bone infections Medical Economics 83(19): 34-37